In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies by Elena Iemma | Apr 1, 2024
In Silico Screening and Immune-Engineering Techniques for “Stealth” Receptor Targets of Immunotherapeutic Antibodies by Annie De Groot | Oct 5, 2018EpiVax_CPI-Targets_04Oct18_forPrinting